Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA pilots real-time clinical trial data monitoring to accelerate drug approvals.
The FDA is launching a pilot program to monitor clinical trial data in real time, aiming to accelerate drug approvals.
The agency will receive aggregated safety and efficacy signals from AstraZeneca and Amgen without accessing raw patient records.
This initiative seeks to reduce development delays by allowing continuous oversight, though safety remains the top priority.
6 Articles
Los pilotos de la FDA monitorean en tiempo real los datos de ensayos clínicos para acelerar las aprobaciones de medicamentos.